BON NATURAL LIFE LIMITED AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
As of | ||||||||
March 31, 2023 | September 30, 2022 | |||||||
ASSETS | ||||||||
CURRENT ASSETS | ||||||||
Cash | $ | 542,272 | $ | 840,861 | ||||
Accounts receivable, net | 9,260,407 | 6,784,307 | ||||||
Inventories, net | 1,803,374 | 1,722,120 | ||||||
Advance to suppliers, net | 7,644,920 | 4,091,990 | ||||||
Acquisition deposit | 1,000,000 | 1,000,000 | ||||||
Prepaid expenses and other current assets | 3,967,756 | 277,509 | ||||||
TOTAL CURRENT ASSETS | 24,218,729 | 14,716,787 | ||||||
Property, plant and equipment, net | 22,135,274 | 21,624,437 | ||||||
Intangible assets, net | 373,751 | 366,167 | ||||||
Right-of-use lease assets, net | 450,282 | 546,690 | ||||||
Deferred tax assets, net | 29,023 | 2,768 | ||||||
TOTAL ASSETS | $ | 47,207,059 | $ | 37,256,849 | ||||
LIABILITIES AND EQUITY | ||||||||
CURRENT LIABILITIES | ||||||||
Short-term loans | $ | 2,666,457 | $ | 2,424,587 | ||||
Current portion of long-term loans | 1,934,411 | 2,135,979 | ||||||
Accounts payable | 324,240 | 214,585 | ||||||
Due to related parties | 120,203 | 72,836 | ||||||
Taxes payable | 1,676,714 | 1,239,708 | ||||||
Deferred revenue | 989,027 | 188,745 | ||||||
Accrued expenses and other current liabilities | 3,503,550 | 114,431 | ||||||
Finance lease liabilities, current | - | 26,285 | ||||||
Operating lease liability, current | 247,397 | 230,182 | ||||||
TOTAL CURRENT LIABILITIES | 11,461,999 | 6,647,338 | ||||||
Long-term loans | 30,336 | 189,813 | ||||||
Operating lease liability, noncurrent | 212,955 | 327,202 | ||||||
TOTAL LIABILITIES | $ | 11,705,290 | $ | 7,164,353 | ||||
COMMITMENTS AND CONTINGENCIES | ||||||||
EQUITY | ||||||||
Ordinary shares, $0.0001 par value, 500,000,000 shares authorized, 11,146,226 and 8,396,226 shares issued and outstanding as of March 31, 2023 and September 30, 2022, respectively | 1,115 | 840 | ||||||
Additional paid in capital | 17,946,174 | 15,711,450 | ||||||
Statutory reserve | 1,804,116 | 1,804,116 | ||||||
Retained earnings | 16,796,529 | 14,676,769 | ||||||
Accumulated other comprehensive income | (1,559,550 | ) | (2,631,171 | ) | ||||
TOTAL BON NATURAL LIFE LIMITED SHAREHOLDERS' EQUITY | 34,988,384 | 29,562,004 | ||||||
Non-controlling interest | 513,387 | 530,492 | ||||||
TOTAL SHAREHOLDERS' EQUITY | 35,501,771 | 30,092,496 | ||||||
TOTAL LIABILITIES AND EQUITY | $ | 47,207,059 | $ | 37,256,849 |
BON NATURAL LIFE LIMITED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME
(UNAUDITED)
For the six months ended March 31, | ||||||||
2023 | 2022 | |||||||
REVENUE | $ | 14,149,967 | $ | 13,688,400 | ||||
COST OF REVENUE | (9,432,619 | ) | (9,652,453 | ) | ||||
GROSS PROFIT | 4,717,348 | 4,035,947 | ||||||
OPERATING EXPENSES | ||||||||
Selling expenses | (136,164 | ) | (83,970 | ) | ||||
General and administrative expenses | (1,465,955 | ) | (998,943 | ) | ||||
Research and development expenses | (129,995 | ) | (164,675 | ) | ||||
Total operating expenses | (1,732,114 | ) | (1,247,588 | ) | ||||
INCOME FROM OPERATIONS | 2,985,234 | 2,788,359 | ||||||
OTHER INCOME (EXPENSES) | ||||||||
Interest income | 8,732 | 589 | ||||||
Interest expense | (178,557 | ) | (277,764 | ) | ||||
Unrealized foreign transaction exchange loss | 8,452 | (16,994 | ) | |||||
Government subsidies | 11,916 | 542,256 | ||||||
Income from short-term investments | - | 12,419 | ||||||
Other income | (223,043 | ) | 43,532 | |||||
Total other income, net | (372,501 | ) | 304,038 | |||||
INCOME BEFORE INCOME TAX PROVISION | 2,617,733 | 3,092,397 | ||||||
INCOME TAX PROVISION | (510,077 | ) | (562,737 | ) | ||||
NET INCOME | 2,102,656 | 2,529,660 | ||||||
Less: net loss attributable to non-controlling interest | (17,104 | ) | (19,018 | ) | ||||
NET INCOME ATTRIBUTABLE TO BON NATURAL LIFE LIMITED | $ | 2,119,760 | $ | 2,548,678 | ||||
NET INCOME | 2,102,656 | 2,529,660 | ||||||
OTHER COMPREHENSIVE INCOME | ||||||||
Total foreign currency translation adjustment | 1,071,621 | 485,503 | ||||||
TOTAL COMPREHENSIVE INCOME | 3,174,277 | 3,015,163 | ||||||
Less: comprehensive loss attributable to non-controlling interest | (17,104 | ) | (21,314 | ) | ||||
COMPREHENSIVE INCOME ATTRIBUTABLE TO BON NATURAL LIFE LIMITED | $ | 3,191,381 | $ | 3,036,477 | ||||
EARNINGS PER SHARE | ||||||||
Basic | $ | 0.24 | $ | 0.31 | ||||
Diluted | $ | 0.24 | $ | 0.30 | ||||
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING | ||||||||
Basic | 8,918,309 | 8,350,381 | ||||||
Diluted | 8,979,243 | 8,386,306 |
BON NATURAL LIFE LIMITED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
FOR THE SIX MONTHS ENDED MARCH 31, 2023 AND 2022
(UNAUDITED)
Common shares | Additional paid-in | Statutory | Retained | Accumulated other comprehensive | Total shareholders' | Non- controlling | Total | |||||||||||||||||||||||||||||
Shares | Amount | capital | reserve | earnings | loss | equity | interest | equity | ||||||||||||||||||||||||||||
Balance at September 30, 2021 | 8,330,000 | $ | 833 | $ | 15,540,433 | $ | 1,050,721 | $ | 9,192,676 | $ | 222,221 | $ | 26,006,884 | $ | 527,865 | $ | 26,534,749 | |||||||||||||||||||
Non-cash exercise of warrants | 20,381 | 2 | (2 | ) | - | - | - | - | - | - | ||||||||||||||||||||||||||
Amortization of share-based compensation | - | - | 89,820 | - | - | - | 89,820 | - | 89,820 | |||||||||||||||||||||||||||
Net income (loss) | - | - | - | - | 2,548,678 | - | 2,548,678 | (19,018 | ) | 2,529,660 | ||||||||||||||||||||||||||
Foreign currency translation adjustment | - | - | - | - | - | 487,799 | 487,799 | (2,296 | ) | 485,503 | ||||||||||||||||||||||||||
Balance at March 31, 2022 | 8,350,381 | $ | 835 | $ | 15,630,251 | $ | 1,050,721 | $ | 11,741,354 | $ | 710,020 | $ | 29,133,181 | $ | 506,551 | $ | 29,639,732 | |||||||||||||||||||
Balance at September 30, 2022 | 8,396,226 | $ | 840 | $ | 15,711,450 | $ | 1,804,116 | $ | 14,676,769 | $ | (2,631,171 | ) | $ | 29,562,004 | $ | 530,492 | $ | 30,092,496 | ||||||||||||||||||
Issuance of ordinary shares in initial public offerings, net | 2,750,000 | 275 | 2,199,725 | - | - | - | 2,200,000 | - | 2,200,000 | |||||||||||||||||||||||||||
Amortization of stock options | - | - | 35,000 | - | - | 35,000 | - | 35,000 | ||||||||||||||||||||||||||||
Net income (loss) | - | -- | - | - | 2,119,760 | - | 2,119,760 | (17,104 | ) | 2,102,656 | ||||||||||||||||||||||||||
Foreign currency translation adjustment | - | - | - | - | 1,071,621 | 1,071,621 | - | 1,071,621 | ||||||||||||||||||||||||||||
Balance at March 31, 2023 | 11,146,226 | $ | 1,115 | $ | 17,946,175 | $ | 1,804,116 | $ | 16,796,529 | $ | (1,559,550 | ) | $ | 34,988,384 | $ | 513,387 | $ | 35,501,771 |
BON NATURAL LIFE LIMITED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
For the six months ended March 31, | ||||||||
2023 | 2022 | |||||||
Cash flows from operating activities | ||||||||
Net income | $ | 2,102,656 | $ | 2,529,660 | ||||
Adjustments to reconcile net income to cash provided by operating activities | ||||||||
Allowance for doubtful accounts | - | 187 | ||||||
Depreciation and amortization | 282,888 | 112,945 | ||||||
Inventory reserve | 105,314 | - | ||||||
Deferred income tax | (25,749 | ) | (28 | ) | ||||
Amortization of operating lease right-of-use assets | 114,179 | 33,122 | ||||||
Amortization of stock options | 35,000 | 89,820 | ||||||
Unrealized foreign currency exchange loss | (8,452 | ) | 16,994 | |||||
Gain on disposal of property and equipment | - | (745 | ) | |||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable | (2,198,450 | ) | (1,265,109 | ) | ||||
Inventories | (124,601 | ) | (515,690 | ) | ||||
Advance to suppliers, net | (3,353,433 | ) | 977,033 | |||||
Prepaid expenses and other current assets | (3,595,458 | ) | (38,795 | ) | ||||
Accounts payable | 100,386 | 165,741 | ||||||
Operating lease liabilities | (115,170 | ) | (30,589 | ) | ||||
Taxes payable | 386,510 | (1,806,543 | ) | |||||
Deferred revenue | 781,183 | (440,032 | ) | |||||
Accrued expenses and other current liabilities | 3,335,205 | 41,452 | ||||||
Net cash used in operating activities | (2,177,992 | ) | (130,577 | ) | ||||
Cash flows from investing activities | ||||||||
Purchase of short-term investments | - | (3,678,199 | ) | |||||
Proceeds upon redemption of short-term investments | - | 5,273,186 | ||||||
Purchase of property and equipment | (15,131 | ) | (10,231 | ) | ||||
Proceeds from sales of property and equipment | - | 1,659 | ||||||
Capital expenditures on construction-in-progress | (2,970 | ) | (3,577,995 | ) | ||||
Net cash used in investing activities | (18,101 | ) | (1,991,580 | ) | ||||
Cash flows from financing activities | ||||||||
Net proceeds from issuance of Ordinary Shares in initial public offerings | 2,200,000 | - | ||||||
Proceeds from short-term loans | 259,767 | 1,608,378 | ||||||
Proceeds from long-term loans | - | 594,864 | ||||||
Repayment of short-term loans | (79,165 | ) | (41,945 | ) | ||||
Repayment of long-term loans | (437,412 | ) | (339,343 | ) | ||||
Proceeds from (repayment of) borrowings from related parties | (1,038 | ) | 91,965 | |||||
Principal repayment of capital lease | (27,236 | ) | (89,465 | ) | ||||
Net cash provided by financing activities | 1,914,916 | 1,824,454 | ||||||
Effect of changes of foreign exchange rates on cash | (17,412 | ) | 2,915 | |||||
Net decrease in cash | (298,589 | ) | (294,788 | ) | ||||
Cash, beginning of period | 840,861 | 1,903,867 | ||||||
Cash, end of period | $ | 542,272 | $ | 1,609,079 | ||||
Supplemental disclosure of cash flow information | ||||||||
Cash paid for interest expense | $ | 178,557 | $ | 277,764 | ||||
Cash paid for income tax | $ | 500,251 | $ | 785,853 | ||||
Supplemental disclosure of non-cash investing and financing activities | ||||||||
Amortization of share-based compensation for initial public offering services | $ | 35,000 | $ | 89,820 | ||||
Right-of-use assets obtained in exchange for operating lease obligations | $ | 458,181 | $ | - |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Bon Natural Life Ltd. published this content on 11 September 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 September 2023 15:06:02 UTC.